CAPTURE 2 risk-adjusted stroke outcome benchmarks for carotid artery stenting with distal embolic protection
To access this article, please choose from the options below
Competition of interest: Dr Matsumura received research support, consultation fees, or training director fees from Abbott, Cook, EV3, Lumen, Medtronic, and WL Gore. Dr Cheng is an employee of sponsor for the clinical trial (Abbott), and Dr Gao and Dr Verta are employees of Abbott.
Additional material for this article may be found online at www.jvascsurg.org.
The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.
PII: S0741-5214(10)00811-6
doi:10.1016/j.jvs.2010.03.064
Published by Elsevier Inc.
